160 related articles for article (PubMed ID: 16139829)
1. Laboratory markers for COPD in "susceptible" smokers.
Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
[TBL] [Abstract][Full Text] [Related]
2. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of biomarkers in asthma and COPD.
Snell N; Newbold P
Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease.
Gessner C; Scheibe R; Wötzel M; Hammerschmidt S; Kuhn H; Engelmann L; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2005 Oct; 99(10):1229-40. PubMed ID: 16140223
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
6. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification.
Merkel D; Rist W; Seither P; Weith A; Lenter MC
Proteomics; 2005 Jul; 5(11):2972-80. PubMed ID: 16075419
[TBL] [Abstract][Full Text] [Related]
7. Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease.
Zervou MI; Tzortzaki EG; Makris D; Gaga M; Zervas E; Economidou E; Tsoumakidou M; Tzanakis N; Milic-Emili J; Siafakas NM
Eur Respir J; 2006 Sep; 28(3):472-8. PubMed ID: 16707512
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite DNA instability in nasal cytology of COPD patients.
Karatzanis AD; Samara KD; Tzortzaki E; Zervou M; Helidonis ES; Velegrakis GA; Siafakas N
Oncol Rep; 2007 Mar; 17(3):661-5. PubMed ID: 17273748
[TBL] [Abstract][Full Text] [Related]
9. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in COPD.
Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
[TBL] [Abstract][Full Text] [Related]
11. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
13. [Chronic obstructive pulmonary disease and genetics].
Ingebrigtsen T; Thomsen SF; Vestbo J; Backer V
Ugeskr Laeger; 2008 Sep; 170(38):2971-3. PubMed ID: 18808751
[TBL] [Abstract][Full Text] [Related]
14. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
Kałucka S
Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
[TBL] [Abstract][Full Text] [Related]
15. [Oxidative stress and genetic polymorphism in COPD].
Dalsgarô OJ; Vestbo J
Ugeskr Laeger; 2002 Aug; 164(35):4056-61. PubMed ID: 12236229
[TBL] [Abstract][Full Text] [Related]
16. Somatic DNA alterations in lung epithelial barrier cells in COPD patients.
Samara KD; Tzortzaki EG; Neofytou E; Karatzanis AD; Lambiri I; Tzanakis N; Siafakas NM
Pulm Pharmacol Ther; 2010 Jun; 23(3):208-14. PubMed ID: 20040382
[TBL] [Abstract][Full Text] [Related]
17. [Development of chronic obstructive pulmonary disease correlates with mini- and microsatellite locus instability].
Chizhikov VV; Chikina SIu; Tatosian AG; Chuchalin AG; Zborovskaia IB
Genetika; 2003 May; 39(5):694-701. PubMed ID: 12838617
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary biomarkers in chronic obstructive pulmonary disease.
Barnes PJ; Chowdhury B; Kharitonov SA; Magnussen H; Page CP; Postma D; Saetta M
Am J Respir Crit Care Med; 2006 Jul; 174(1):6-14. PubMed ID: 16556692
[TBL] [Abstract][Full Text] [Related]
19. [The genetics of chronic obstructive pulmonary disease].
Arinir U; Hoffjan S; Knoop H; Schultze-Werninghaus G; Epplen JT; Rohde G
Pneumologie; 2009 Jan; 63(1):41-8. PubMed ID: 19137504
[TBL] [Abstract][Full Text] [Related]
20. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
